ABSTRACT
Following a landmark clinical trial, the vaccine against Haemophilus influenzae type b (Hib) was introduced in The Gambia in 1997. Whilst the immunogenicity of this vaccine is well established subsequent to the doses administered under the EPI schedule, little data exists assessing longevity of protection, using serology. Such data are needed however to predict the susceptibility to Hib at the population level. To determine antibody persistence in 5-6 year old fully vaccinated Gambian children compared with older children, adolescents and young adults, 427 serum samples from healthy 5-37 year old participants were tested for Hib antibodies using VaccZyme Human Anti-Hib ELISA kits. 86% of the children who had received 3 doses of Hib vaccine in infancy had Hib antibody concentrations ≥0.15 mg/l at the age of 5-6 years. This proportion was 76% for adolescents who had also largely been vaccinated and 90% for adults who had never received Hib vaccine. Although most participants had anti-Hib antibody above concentrations putatively defined as protective, significantly fewer had concentrations thought to confer long-term protection. This suggests a population with insufficient or waning antibody that may be susceptible to breakthrough disease and transmission.
Subject(s)
Antibodies, Bacterial/blood , Haemophilus Infections/epidemiology , Haemophilus influenzae type b , Adolescent , Adult , Antigens, Bacterial/blood , Bacterial Capsules , Child , Child, Preschool , Female , Gambia/epidemiology , Haemophilus Infections/prevention & control , Haemophilus Vaccines/therapeutic use , Healthy Volunteers , Humans , Immunization Schedule , Male , Young AdultABSTRACT
Human newborns are vulnerable to infectious diseases that account for majority of the morbidity and mortality, particularly in first year of life. Vaccines have become the most effective public health intervention strategy to curtail the prevalence of these infectious diseases. Although vaccines against a number of diseases exist, there are no vaccines against many other diseases that commonly affect children. The adequate assessment of immune responses to vaccines is an important step in the development of vaccines. However, a number of biological and "non-medical" socio-economic and ethical factors could influence either the administration and/or evaluation of vaccines in infants. Recognition and understanding of these determinants are crucial in planning interventions and for logical interpretations of results.
Subject(s)
Immunization Programs/economics , Immunization Programs/ethics , Vaccines/administration & dosage , Vaccines/immunology , Developing Countries , Female , Humans , Infant , Infant, Newborn , Male , Public Health , Socioeconomic Factors , Vaccines/economicsABSTRACT
BACKGROUND: The attitude of healthcare workers (HCW) towards organ donation is cardinal to the successful implementation and sustainability of transplant programs. We present the outcome of a survey among HCW in a single tertiary institution in Nigeria regarding their willingness to be living-related kidney donors. METHODS: Self-administered questionnaires were randomly distributed to HCW evaluating their attitude towards living-related kidney donation. RESULTS: Of the 650 questionnaires distributed only 502 responded (clinical medical students 51%, physicians 31.7% and nurses 17.3%); 75.6% of respondents were willing to be living donors while 5.8% were against it, and 18.5% were undecided. Multivariate analysis identified willingness to receive, perceived risk associated with kidney donation, and attitude towards cadaveric donation as independent predictors of willingness of HCW to be living donors. CONCLUSION: Nigerian HCW have a positive attitude toward kidney donation.
